Жестяк че творица канешна
180 Life Sciences (NASDAQ: ATNF) has announced a significant strategic pivot with a $425 million private placement to establish an Ethereum treasury reserve. The company plans to rebrand as ETHZilla Corporation and will primarily use the proceeds to purchase Ether (ETH). The PIPE transaction, expected to close around August 1, 2025, involves over 60 institutional and crypto-native investors.
Over 60 institutional and crypto-native investors in the PIPE transaction including Harbour Island, Electric Capital, Polychain Capital, GSR, Omicron Technologies, Konstantin Lomashuk (Co-Founder Lido and p2p.org), Sreeram Kannan (Founder, Eigenlayer), Mike Silagadze (Founder, Ether.fi), Danny Ryan (Co-Founder, Etherealize), Vivek Raman (Co-Founder, Etherealize), Sam Kazemanian (Co-Founder, Frax), Grant Hummer (Co-Founder of Etherealize), Robert Leshner (Founder, Compound and Superstate), Tarun Chitra (Founder, Gauntlet) and several other prominent Ethereum ecosystem founders and leaders.
Корпорации совершенно рутинно готовятся выкупать Эфир по полмиллиарда долларов
Эфирная экосистема нацелилась на 125 триллионый рынок акций, который с GENIUS уже открывает свои двери
Интересно интересно, каким будет финал ETH этого цикла. 10к понятно будет. 20к, много, мало?
